
Drugs
Substances by international nonproprietary name (INN) and ATC code, with their current status.
Search the catalog
Filters1
Closeness to humans
Closeness to humans:Proven efficacy in humans
Order:Newest
26 cards found
Card descriptions are written in Russian for now; English text is coming.
Atezolizumab
Approvedatezolizumab
On 8 October 2026 the FDA approved atezolizumab with fluoropyrimidine and oxaliplatin chemotherapy as adjuvant treatment of stage III mismatch repair deficient (dMMR) colon cancer, based on the open-label phase 3 ATOMIC trial (NCT02912559) in 711 adults and one child after complete resection: disease-free survival hazard ratio 0.50 (95% CI 0.35-0.73); median DFS not reached in either arm. The FDA notice reports no overall-survival comparison.
1 news item
Retatrutide
In clinical trialsretatrutide
Агонист рецепторов GIP, GLP-1 и глюкагона, инъекция раз в неделю. Опубликованы испытания фазы 2 (ожирение, сахарный диабет 2 типа, MASLD) и фазы 3 TRIUMPH-1, TRIUMPH-2 и TRANSCEND-T2D-1; опубликованных результатов по сердечно-сосудистым исходам и смертности пока нет. На начало октября 2026 не одобрен FDA и EMA.
3 news items